Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1434-9949

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells ; volume:37 ; number:6 ; day:15 ; month:3 ; year:2018 ; pages:1597-1604 ; date:6.2018
Clinical rheumatology ; 37, Heft 6 (15.3.2018), 1597-1604, 6.2018

Creator: Schramm-Luc, Agata

Contributor: Schramm, Jolanta
Siedliński, Mateusz
Guzik, Tomasz J.
Batko, Bogdan
SpringerLink (Online service)

DOI: 10.1007/s10067-018-4061-y

URN: urn:nbn:de:101:1-2018071520065507708247

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schramm-Luc, Agata
Schramm, Jolanta
Siedliński, Mateusz
Guzik, Tomasz J.
Batko, Bogdan
SpringerLink (Online service)

Other Objects (12)

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Age determines response to anti-TNFα treatment in patients with ankylosing spondylitis and is related to TNFα-producing CD8 cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Treatment of ankylosing spondylitis with TNFα inhibitors does not affect serum levels of tryptophan metabolites

Genetic association between TNF-α −857 C/T polymorphism and ankylosing spondylitis susceptibility: evidence from a meta-analysis

A case study: consequences of ANTI-TNFα therapy and foot ulcerations. A patient with Ankylosing Spondylitis (AS) treated with Infliximab

Correction to: Secukinumab: A Review in Ankylosing Spondylitis

Andersson lesion in ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors

ETS1 variants confer susceptibility to ankylosing spondylitis in Han Chinese

Prevalence and factors related to sleep apnoea in ankylosing spondylitis

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis

Related objects

Reset password